Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Ambrx, Eli Lilly, Merck deal

Ambrx and LLY will use Ambrx's ReCODE (reconstituted chemically orthogonal directed engineering) protein optimization technology to discover and

Read the full 187 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE